个人简介

赵婷婷,博士,中日友好医院临床医学研究所研究员,协和医科大学博士生导师、北京医科大学和首都医科大学硕士生导师。曾于20122013年赴香港中文大学李嘉诚健康研究所访问,于2017.0912赴美国耶鲁大学肾脏病系访问。

先后主持科技部重大新药创制课题、国家自然科学基金项目,北京市自然科学基金面上项目等课题17项。发表论文76篇,作为副主编出版专著《糖尿病肾病中西医结合诊疗与研究》,获得国家科技进步二等奖1项,省部级以上学术奖励奖4项。近5年,以第一作者/通讯作者发表SCI文章20篇,获得国家发明专利3项。兼任IntegrativeMedicineinNephrologyandAndrology编委,国家自然科学基金同行评议专家、中国中西医结合学会肾脏病专业委员会青年委员,中华中医药学会中药实验药理分会青年委员、世界中联肾病专业委员会第三届理事会理事等社会职务。

研究方向

(1)中药治疗慢性肾脏病机制研究和新药研发

(2)肠道微生物参与糖尿病肾病机制研究

(3)多脏器代谢共病机制与药理研究

合作或招生需求

(1)常年招收基础医学、病理生理学、中西医结合基础、药理学等相关专业联合培养研究生。

(2)研究生对科研有较强的兴趣,勤奋努力,具有良好的沟通能力。

联系方式:ttfrfr@163.com

出版专著

(1)《糖尿病肾病中西医结合诊疗与研究》李平、谢院生主编,赵婷婷副主编,中国医药科技出版社,2018

近三年代表性学术论文

1.LiH,LiY,ZhangB,ChengW,MaG,RongJ,DuanS,FengD,ZhaoT.Spatialmetabolomics:Anewtoolforunravellingthemetabolicdisordersandheterogeneityindiabetickidneydisease(Review).IntJMolMed.2026Apr;57(4):76.

2.LiY,HongG,PengL,ZhangB,WangS,GaoM,DongX,WanY,RongJ,ChenK,SuH,LiP*,ZhangY*,ZhaoT*(赵婷婷,共同通讯).TangshenformulaalleviatesdoxorubicininducednephrotoxicitybyregulatingBAXcrosstalkinpodocyte.Phytomedicine.2025Jun20;145:156858.

3.LiQ,MaG,CuiY,ChenY,GuoP,FengD*,ZhaoT*(赵婷婷,共同通讯).Studyofendocrinedisruptingeffectsofdisposablebiodegradabletablewareandkeymigrantsbasedoninvitroassays,massspectrometryanalysis,andinsilicopredictions.EcotoxicolEnvironSaf.2025Jul15;300:118446.

4.MaG,CuiY,LiQ,ChenY,GuoP,FengD*,ZhaoT*(赵婷婷,共同通讯).Endocrinedisruptingeffectsof24colorantsusedinfoodcontactmaterials:Invitroandinsilicostudies.FoodChemToxicol.2025Jun;200:115410.

5.RongJ,ZhangZ,PengX,LiP*,ZhaoT*(赵婷婷,共同通讯),ZhongY*.Mechanismsofhepaticandrenalinjuryinlipidmetabolismdisordersinmetabolicsyndrome.IntJBiolSci.2024Sep9;20(12):47834798.

6.WangS,LiX,ZhangB,LiY,ChenK,QiH,GaoM,RongJ,LiuL,WanY,DongX,YanM,MaL,LiP*,ZhaoT*(赵婷婷,共同通讯).TangshenformulatargetsthegutmicrobiotatotreatnonalcoholicfattyliverdiseaseinHFDmice:A16SrRNAandnontargetedmetabolomicsanalyses.BiomedPharmacother.2024Apr;173:116405.

7.GaoM#,ZhaoT#(赵婷婷,共同一作),ZhangC#,LiP#,WangJ,HanJ,ZhangN,PangB,LiuS.FerritinophagymediatedironcompetitioninRUTIs:TugofwarbetweenUPECandhost.BiomedPharmacother.2023Jul;163:114859.

8.WanY,WangS,ChenK,LiuL,WangX,ZhangB,HuL,LiuS,ZhaoT*.(赵婷婷,共同通讯),QiH*.HighsulfatedderivativeofpolysaccharidefromUlvapertusaimprovesAdriamycininducednephroticsyndromebysuppressingoxidativestress.FoodFunct.2023Sep18.

9.WangS,ZhangB,ChangX,ZhaoH,ZhangH,ZhaoT*.(赵婷婷,共同通讯),QiH*.Potentialuseofseaweedpolysaccharidesasprebioticsformanagementofmetabolicsyndrome:areview.CritRevFoodSciNutr.2023Mar27:121.

10.ZhaoT(赵婷婷),ZhouQ.Editorial:MolecularPathophysiologyofDiabetesRelatedOrganInjury.FrontMed(Lausanne).2022Mar18;9:875444.doi:10.3389/fmed.2022.875444.

11.WanY,LiuL,ZhangB,WangS,WangX,ChenK,LiY,ZhaoT*.(赵婷婷,共同通讯),QiH*.StructuralCharacterizationandAntiNonalcoholicFattyLiverEffectofHighSulfatedUlvapertusaPolysaccharide.Pharmaceuticals(Basel).2022Dec31;16(1):62.

12.ZhangB,WanY,ZhouX,ZhangH,ZhaoH,MaL,DongX,YanM,ZhaoT*.(赵婷婷,共同通讯)andLiP*(2022)CharacteristicsofSerumMetabolitesandGutMicrobiotainDiabeticKidneyDisease.Front.Pharmacol.13:872988.

13.HuL,WangY,WanY,MaL,ZhaoT*.(赵婷婷,共同通讯),LiP*.TangshenFormulaImprovesDiabetesAssociatedMyocardialFibrosisbyInhibitingTGFβ/SmadsandWnt/βCateninPathways.FrontMed(Lausanne).2021;8:732042.

14.ZhaoTT(赵婷婷),ZhangHJ,YinXB,ZhaoHL,YanMH,PengL,WangQ,DongX,LiP.TangshenformulamodulatesgutMicrobiotaandreducesgutderivedtoxinsindiabeticnephropathyrats.Biomedicine&Pharmacotherapy2020,129,110325.

15.WangQ,TianX,ZhouW,WangY,ZhaoH,LiJ,ZhouX,ZhangH,ZhaoT*.(赵婷婷,共同通讯),&LiP*.(2020).ProtectiveRoleofTangshenFormulaontheProgressionofRenalDamageindb/dbMicebyTRPC6/Talin1PathwayinPodocytes.Journalofdiabetesresearch,2020,3634974.17

16.WangQ,TianX,WangY,ZhaoT(赵婷婷,共同通讯)*,PingLi*.RoleofTransientReceptorPotentialCanonicalChannel6(TRPC6)inDiabeticKidneyDiseasebyRegulatingPodocyteActinCytoskeletonRearrangement.JournalofDiabetesResearch.2020,2020:6897390.

17.LiX,LiX,ZhangQ*,ZhaoT*.(赵婷婷,共同通讯).LowmolecularweightfucoidananditsfractionsinhibitrenalepithelialmesenchymaltransitioninducedbyTGF1orFGF2.InternationalJournalofBiologicalMacromolecules.2017,Pt2(105):14821490.

18.YaoY,YuYC,CaiMR,ZhangZQ,BaiJ,WuHM,LiP,ZhaoTT*(赵婷婷,共同通讯),NiJ*,YinXB*.UPLCMS/MSmethodforthedeterminationoftheherbcompositionofTangshenformulaandtheinvivopharmacokineticsofitsmetabolitesinratplasma.PhytochemAnal.2022,33(3):402426.

19.HanJ,WangX,HouJ,LiuY,LiuP,ZhaoT*(赵婷婷).UsingNetworkPharmacologytoExploretheMechanismofPeachKernelSafflowerintheTreatmentofDiabeticNephropathy.BiomedResInt.2021Feb1;2021:6642584.

20.LiuY,ChenDQ,HanJX,ZhaoTT*(赵婷婷,共同通讯),LiSJ*.AReviewofTraditionalChineseMedicineinTreatingRenalInterstitialFibrosisviaEndoplasmicReticulumStressMediatedApoptosis.BiomedResInt.2021May15;2021:6667791.